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Abstract 
BACKGROUND: In 1882, the German pathologist Friedrich Daniel von Recklinghausen described a series of 
patients with a combination of cutaneous lesions and tumours of the peripheral and central nervous system. 
Succeeding this paper, all of the patients with similar symptoms were given the diagnosis “von Recklinghausen 
disease”. In the 20th century, a distinction was made between Neurofibromatosis type 1 (NF1) and 
Neurofibromatosis type 2 (NF2) with the help of molecular testing. 
CASE REPORT: We are presenting the results from multiple surgical esthetic and reconstructive surgical 
procedures performed on a female patient with severe congenital neurofibromatosis during 15 years (2000-2015). 
The external appearance of our patient was not reflected in the general public’s beauty standards. Convinced that 
she was unusual and unaccepted by the society, she gathered all of the strength and became our patient at 15 
years of age.  
CONCLUSION: Transforming the patient’s life in the next fifteen years improved her overall health and her life 
quality. 
 
 
 
 
 
 
 
 
 
Introduction 
 
In 1768, Akenside was the first one to publish 
a scientifically-based description of a disease that 
later has been described as Neurofibromatosis type 1 
[1]. At that time, he had acknowledged that the 
monsters of scholars, such as Pare and Aldrovandi, 
suffered from a disorder of the nerves [2]. The 
neurofibromas of NF1 were first described in details 
by Smith in 1849 [2]. In 1882, the German pathologist 
Friedrich Daniel von Recklinghausen described a 
series of patients with a combination of cutaneous 
lesions and tumours of the peripheral and central 
nervous system [1]. Succeeding this paper, all of the 
patients with similar symptoms were given the 
diagnosis “von Recklinghausen disease”. 
In the 20th century, a distinction was made 
between Neurofibromatosis type 1 (NF1) and 
Neurofibromatosis type 2 (NF2) with the help of 
molecular testing. NF1 evolved from the von 
Recklinghausen disease, a name which now is only 
an antiquated synonym for the disease [3]. It has been 
estimated that in 1 out of every 2500 to 3500 
individuals are affected, and only one half are results 
of the inherited (familial) disorder. The remaining half 
is considered to be sporadic (de-novo) mutations [4]. 
The classic manifestation of café-au-lait macules, 
axillary or inguinal freckling, iris hamartomas (Lisch 
nodules) and neurofibromas. These findings usually 
prompt further clinical examination, sometimes 
requiring genetic testing (in questionable cases) for 
the mutation of the NF1 gene on chromosome 
17q11.2. The consensus for diagnosis of NF1 was 
developed by the NIH (National Institute of Health) at 
the National Institutes of Health Consensus 
Development Conference in 1987, later updated in 
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1997, which required having two or more of the 
clinical features shown in Table 1 [5], [6], [7]. 
Table 1: Clinical features of the patient 
NIH diagnostic criteria for neurofibromatosis type 1 
6+ café-au-lait macules (prepubertal individuals: bigger than 5 mm and postpubertal 
individuals: bigger than 15 mm) 
Axillary or inguinal freckling 
Neurofibromas (2 or more) or one Plexiform neurofibroma  
Optic glioma 
Iris hamartoma (Lisch nodules, 2 or more) 
Bone lesions (sphenoid dysplasia, medullary narrowing or cortical thickening of long bone 
cortex with or without pseudoarthrosis) 
First degree relative with NF1 
 
Ethical Approval: Our patient has been 
informed of potential publication, has given her 
consent, and all steps to ensure patient confidentiality 
have been taken. 
 
 
Case Presentation 
 
The female patient was only 15 years of age 
when first presented to our hospital. The first 
impression was remarkable for her innumerable skin 
neurofibromas and skeletal abnormalities. Born in 
1985 in a small mountain village in the eastern part of 
Republic of Macedonia, she spends almost her entire 
life hiding from the public due to her external 
appearance. Living in an isolated area of a third world 
country additionally limited her to access appropriate 
medical care.  
The patient had neurofibromas involving 
almost all anatomical regions of the body, most 
prominent on the face, head, thorax, hands, feet and 
the inguinal area. The neurofibromas were ranging in 
size (from 0.5 to 10 cm in greatest dimension) and in 
addition to their location were incapacitating her daily 
living. The patient was not able to walk or use her 
hands. In addition to the neurofibromas, the patient 
had multiple café-au-lait macules and cervical 
ankyloses.  
The MRI of the head, kyphosis of the spine 
and ankyloses of the thoracolumbar part, are 
combined with the different size of round and fairly 
well-circumscribed nodules. Also, there is 
neurofibroma in the subcutaneous soft tissue in the 
forehead, nasal area, intraoral region, upper and 
lower extremities, sternum, spine and gluteal regions. 
Serial blood laboratory tests were performed and were 
within normal limits. The genetic evaluation was not 
performed for definitive in addition to the clinical 
diagnosis since it was compliant with the NIH NF1 
diagnostic criteria (see Table1). However, maybe one 
of the most debilitating aspects of the patient’s life 
was her emotional status. Her mental status and 
intellect were appropriate for her age, and she was 
attending school until graduation from high school. 
The everyday stress due to her presence and the 
constant unpleasant remarks from her peers were 
leaving scars in her soul much bigger and unbearable 
if compared to any surgical scars.  
After multiple surgical procedures, the results 
come slowly. She understood and accepted our plan 
saying “I am a beast, please help me” with despair but 
and not very hopeful for the future.  
The first surgery was performed with general 
anaesthesia on June 28
th
 2000, with concentration to 
the lesions on her face, especially bulky nose and her 
head (Figure 1). 
 
Figure 1: A) Pre-operative presentation (June 28, 2000); B) Pre-
operative presentation (June 28, 2000); C) Initial surgery, removal 
of facial lesion (June 28, 2000)  
 
The second surgery was done the following 
year in local anaesthesia, since the patient was 
already experienced and familiar with what to expect. 
The patient continued to return almost annually for the 
removal of the lesions.  
On March 30
th
 2011, we came to the point 
when her psychological and overall health was 
improving, and we could concentrate more on the 
smaller lesions on her body which will improve her 
quality of life even more.  
a) 
 
b) 
 
Figure 2: March 30, 2011 
 
Our focus was aimed at restoring her fine 
motor movement by removing the digital lesions 
(Figure 2a) and multiple lesions on her bilateral feet, 
including the lesions affecting the toes (Figure 2b).  
After this surgery, the fine motor movements, 
and use of her hands in general drastically improved. 
On December 7
th
 2012, multiple large and diffuse 
subcutaneous lesions were removed from her anterior 
thorax region (Figure 3a). The last time we saw the 
patient was on December 10
th
 2015. She was 
functioning on her own and much more independent 
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than the time we first met her (Figure 3b).  
a) 
 
b) 
 
Figure 3: December 7, 2012 
 
The histopathological evaluation of the 
multiple lesions throughout the years was consistent, 
showing spindle-cells shaped cells with a scant 
amount of cytoplasm separated by collagen fibres and 
myxoid material (Figure 4).  
 
Figure 4: Spindles cells in the fibrous stroma (H&E, 200x) 
 
Immunohistochemical staining with S-100 
highlighted the fraction of the cells (Figure 5). Some of 
the lesions were small (less than 2.0 cm), and others 
was larger, diffuse and involving nerves (Figure 6). No 
apparent malignant transformation was identified [8]. 
 
Figure 5: S-100 highlights the Schwann cells (S-100, 200x) 
Discussion 
 
Neurofibromatosis type 1 is a genetic disorder 
that predominantly affected our patient’s look [2]. The 
shame of her physical disabilities attributed to the 
delay in her family seeking medical help for the 
multiple deformities [4]. The progression of 
fibromatoses nodules affected nerves and combined 
with her spinal ankyloses had limited her mobility, 
making her dependent on her mother.  
a)
 
b)
 
c) 
 
Figure 6: a) MRI of the head; b) MRI of the body; c) MRI of the 
spine  
 
The solution for the inability to walk the family 
had overcome by carrying the patient rather than 
seeking a permanent medical solution. None of the 
siblings or close relatives is known to have NF-1, 
which is not an uncommon finding. Her surgical 
treatments have abruptly stopped in 2015, after the 
death of her mother who was her principal caregiver 
and support throughout her life. 
The initial operation involved removing the 
huge neurofibromas from the head and face region. 
Within the subsequent fifteen years (2000 – 2015) an 
additional ten surgical procedure was performed in 
various regions of her body, all of them in local 
anaesthesia. Her wounds were healing fairly quickly. 
In each of the wounds, only one drain was left for only 
one day. We performed to used stitches Vicryl 4-0. No 
complications were observed, including infections and 
keloid formations. After the removal of numerous 
neurofibromas, we release some peripheral nerves 
structures, and she has achieved complete restoration 
of movement in her upper extremities to the point that 
she can perform delicate tasks with her hands.  Our 
last communication was 16.09.2018 when she gave 
us the consent form to publish her pictures. 
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In conclusion, the goal of any esthetic 
intervention in congenital disorder illness is to re-
establish near “normal” contour. Immediate results are 
evident on the patient’s psychological wellbeing. The 
elimination of unusual appearance contributed and 
brought out our patient’s pleasant appeal to those that 
surround her. 
The known risk of malignant transformation of 
the plexiform and intraneural neurofibromas currently 
has been estimated to be up to 5-10%. Aside from the 
risk of malignant transformation and deceptive 
physical deformity, psychological trauma, such as 
depression and anxiety, almost inevitably accompany 
physical deformities. Often the suffering does not end 
with only the patient but continues with the family thus 
burdening a wider circle of people.  
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